Skip to main content

Advertisement

SpringerLink
Log in

Chitosan–EDTA New Combination is a Promising Candidate for Treatment of Bacterial and Fungal Infections

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Chitosan is an attractive preparation widely used as a pharmaceutical excipient. This study aimed to evaluate the antimicrobial activities of chitosan derivatives, EDTA, and the newly developed chitosan–EDTA combination against Gram-negative and Gram-positive bacteria as well as Candida albicans. Antimicrobial activity was studied. Both minimal Inhibitory Concentrations (MIC) and minimal biocidal concentrations (MBC) were determined. Chitosan acetic acid recorded lower MIC values against Enterococcus faecalis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans than those exhibited by EDTA. EDTA failed to have inhibitory activity against Enterococcus faecalis as well as MBC against any of the studied microorganisms. Chitosan acetic acid’s MBC were recorded to all examined species. Checkerboard assay results indicated a synergistic antimicrobial activity of the new combination against Staphylococcus aureus and an additive effect against other microorganisms. Moreover, a short microbial exposure to chitosan–EDTA (20–30 min) caused complete eradication. Due to the continuous emergence of resistant strains, there is an urgent need to discover new antimicrobial agents. Our findings suggest the use of chitosan as an enhancing agent with antibacterial and antifungal properties in combination with EDTA in pharmaceutical preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Al-Bakri AG, Othman G, Bustanji Y (2009) The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents. J Appl Microbiol 107(1):280–286

    Article  PubMed  CAS  Google Scholar 

  2. Taha MO, Al-Bakri AG, Zalloum WA (2006) Discovery of potent inhibitors of pseudomonal quorum sensing via pharmacophore modeling and in silico screening. Bioorg Med Chem Lett 16(22):5902–5906

    Article  PubMed  CAS  Google Scholar 

  3. Roberts GAF (1992) Chitin chemistry. Palgrave Macmillan, London

  4. Cheng CY, Li YK (2000) An Aspergillus chitosanase with potential for large-scale preparation of chitosan oligosaccharides. Biotechnol Appl Biochem 32(Pt 3):197–203

    Article  PubMed  CAS  Google Scholar 

  5. Gavini E et al (2002) Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSciTech 3(3):E20

    Article  PubMed  Google Scholar 

  6. Tin S et al (2009) Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa. Int J Biol Sci 5(2):153–160

    PubMed  CAS  Google Scholar 

  7. Raad I et al (2007) Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51(1):78–83

    Article  PubMed  CAS  Google Scholar 

  8. Reardon DM, Warner B, Trowbridge EA (1991) EDTA, the traditional anticoagulant of haematology: with increased automation is it time for a review? Med Lab Sci 48(1):72–75

    PubMed  CAS  Google Scholar 

  9. Vaara M (1992) Agents that increase the permeability of the outer membrane. Microbiol Rev 56(3):395–411

    PubMed  CAS  Google Scholar 

  10. Ashour HM, El-Sharif A (2007) Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients. J Clin Oncol 25(36):5763–5769

    Article  PubMed  Google Scholar 

  11. Ashour HM, El-Sharif A (2009) Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med 7:1–14

    Article  Google Scholar 

  12. Drago L, De Vecchi E, Nicola L, Gismondo MR (2007) In vitro evaluation of antibiotics’ combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Dis 7:111

    Article  PubMed  Google Scholar 

  13. Black JG (1999) Microbiology : principles and explorations, 4th edn, International edn. Upper Saddle River, N.J.: Prentice Hall International; [Great Britain : Wiley]. 1 v. (various pagings)

  14. Schwalbe R, Steele-Moore L, Goodwin AC (2007) Antimicrobial susceptibility testing protocols. CRC Press, Boca Raton, p 414

    Google Scholar 

  15. Cooper R, Jenkins L (2009) A comparison between medical grade honey and table honeys in relation to antimicrobial efficacy. Wounds 21(2):29–36

    Google Scholar 

  16. Wang WH et al (2003) Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 52(4):490–495

    Article  PubMed  CAS  Google Scholar 

  17. Harrison JJ, Turner RJ, Ceri H (2007) A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents. FEMS Microbiol Lett 272(2):172–181

    Article  PubMed  CAS  Google Scholar 

  18. White RL et al (1996) Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 40(8):1914–1918

    PubMed  CAS  Google Scholar 

  19. Bosso JA (2005) The antimicrobial armamentarium: evaluating current and future treatment options. Pharmacotherapy 25(10 Pt 2):55S–62S

    Article  PubMed  CAS  Google Scholar 

  20. Fazly-Bazzaz BS, Khajehkaramadin M, Shokooheizadeh HR (2005) In vitro antibacterial activity of Rheum ribes extract obtained from various plant parts against clinical isolates of Gram-negative pathogens. Iranian J Pharm Res 2:87–91

    Google Scholar 

  21. Falagas ME et al (2005) Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5(1):24

    Article  PubMed  Google Scholar 

  22. Gomez J et al (2009) Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993–1998 versus 2002–2005). Rev Iberoam Micol 26(3):184–188

    Article  PubMed  Google Scholar 

  23. Mehta M, Dutta P, Gupta V (2005) Antimicrobial susceptibility pattern of blood isolates from a teaching hospital in north India. Jpn J Infect Dis 58(3):174–176

    PubMed  CAS  Google Scholar 

  24. Raafat D et al (2008) Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol 74(12):3764–3773

    Article  PubMed  CAS  Google Scholar 

  25. Zhong Z et al (2009) Antimicrobial activity of hydroxylbenzenesulfonailides derivatives of chitosan, chitosan sulfates and carboxymethyl chitosan. Int J Biol Macromol 45(2):163–168

    Article  PubMed  CAS  Google Scholar 

  26. Aksungur P et al (2004) Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Control Release 98(2):269–279

    Article  PubMed  CAS  Google Scholar 

  27. Loretz B, Bernkop-Schnurch A (2006) In vitro evaluation of chitosan–EDTA conjugate polyplexes as a nanoparticulate gene delivery system. AAPS J 8(4):E756–764

    Article  PubMed  CAS  Google Scholar 

  28. Banin E, Brady KM, Greenberg EP (2006) Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72(3):2064–2069

    Article  PubMed  CAS  Google Scholar 

  29. Kite P et al (2004) Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42(7):3073–3076

    Article  PubMed  CAS  Google Scholar 

  30. Percival SL et al (2005) Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26(6):515–519

    Article  PubMed  Google Scholar 

  31. Sherertz RJ et al (2006) Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 50(5):1865–1868

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no potential conflicts of interest. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

    Amany A. El-Sharif

  2. Egyptian Petroleum Research Institute (EPRI), Nasr City, Cairo, Egypt

    Mohamed H. M. Hussain

Authors
  1. Amany A. El-Sharif
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed H. M. Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amany A. El-Sharif.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Sharif, A.A., Hussain, M.H.M. Chitosan–EDTA New Combination is a Promising Candidate for Treatment of Bacterial and Fungal Infections. Curr Microbiol 62, 739–745 (2011). https://doi.org/10.1007/s00284-010-9777-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00284-010-9777-0

Keywords

Search

Navigation